Frederik Wenz, MD CHICAGO—Bone remodeling markers may be useful for diagnosing and following prostate and breast cancer patients with bone metastases, according to researchers. Baseline levels of ICTP ...

A phase I study of IPH2101, a novel anti-inhibitory KIR monoclonal antibody, in patients with multiple myeloma. Background: Aminobisphosphonates (aBP) are standard of care for myeloma related bone ...

Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases Results from Studies of Other Investigational Merck Cancer ...

Please provide your email address to receive an email when new articles are posted on . Results showed bone quality was abnormal in ankle arthritis on the affected side. However, bone quality was ...

Please provide your email address to receive an email when new articles are posted on . SANTA FE, N.M. — In this video exclusive, Jacques P. Brown, MD, discusses clinical applications of bone turnover ...

Tumor suppressor genes (TSG), treatment, and survival in de novo metastatic hormone-sensitive prostate cancer. Multivariate Cox proportional hazard model for PFS and OS. Bone Pain (yes vs No) 1.52, ...

Youths with type 1 diabetes (T1D) show lower bone accrual than expected for their age, gender, pubertal stage, lean mass accrual, and growth, with greater urinary calcium excretion being associated ...

A team of Brazilian researchers has produced a graphene-based scaffold that, when implanted into broken rat tibias, drove ...